Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov;112(11):1985-1991.
doi: 10.1111/add.13904. Epub 2017 Jul 17.

Loose regulation of medical marijuana programs associated with higher rates of adult marijuana use but not cannabis use disorder

Affiliations

Loose regulation of medical marijuana programs associated with higher rates of adult marijuana use but not cannabis use disorder

Arthur Robin Williams et al. Addiction. 2017 Nov.

Abstract

Background and aims: Most US states have passed medical marijuana laws (MMLs), with great variation in program regulation impacting enrollment rates. We aimed to compare changes in rates of marijuana use, heavy use and cannabis use disorder across age groups while accounting for whether states enacted medicalized (highly regulated) or non-medical mml programs.

Design: Difference-in-differences estimates with time-varying state-level MML coded by program type (medicalized versus non-medical). Multi-level linear regression models adjusted for state-level random effects and covariates as well as historical trends in use.

Setting: Nation-wide cross-sectional survey data from the US National Survey of Drug Use and Health (NSDUH) restricted use data portal aggregated at the state level.

Participants: Participants comprised 2004-13 NSDUH respondents (n ~ 67 500/year); age groups 12-17, 18-25 and 26+ years. States had implemented eight medicalized and 15 non-medical MML programs.

Measurements: Primary outcome measures included (1) active (past-month) marijuana use; (2) heavy use (> 300 days/year); and (3) cannabis use disorder diagnosis, based on DSM-IV criteria. Covariates included program type, age group and state-level characteristics throughout the study period.

Findings: Adults 26+ years of age living in states with non-medical MML programs increased past-month marijuana use 1.46% (from 4.13 to 6.59%, P = 0.01), skewing towards greater heavy marijuana by 2.36% (from 14.94 to 17.30, P = 0.09) after MMLs were enacted. However, no associated increase in the prevalence of cannabis use disorder was found during the study period. Our findings do not show increases in prevalence of marijuana use among adults in states with medicalized MML programs. Additionally, there were no increases in adolescent or young adult marijuana outcomes following MML passage, irrespective of program type.

Conclusions: Non-medical marijuana laws enacted in US states are associated with increased marijuana use, but only among adults aged 26+ years. Researchers and policymakers should consider program regulation and subgroup characteristics (i.e. demographics) when assessing for population level outcomes. Researchers and policymakers should consider program regulation and subgroup characteristics (i.e. demographics) when assessing for population level outcomes.

Keywords: Adolescent drug use; cannabis use disorder; epidemiology; marijuana; medical marijuana laws; public health; state policy.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests

None.

Figures

Figure 1
Figure 1
Trends in past-month marijuana use, heavy marijuana use (> 300 days/year) and marijuana use disorder among individuals aged 12–17 years. MML = medical marijuana law
Figure 2
Figure 2
Trends in past-month marijuana use, heavy marijuana use (> 300 days/year) and marijuana use disorder among individuals aged 18–25 years. MML = medical marijuana law
Figure 3
Figure 3
Trends in past-month marijuana use, heavy marijuana use (> 300 days/year) and marijuana use disorder among individuals aged > 26 years. MML = medical marijuana law

References

    1. Williams AR. Medical and recreational marijuana policy: from prohibition to the rise of regulation. In: Compton M, editor. Marijuana and Mental Health. Arlington, VA: American Psychiatric Publishing Inc; 2016. pp. 39–70.
    1. Fairman BJ. Trends in registered medical marijuana participation across 13 US states and District of Columbia. Drug Alcohol Depend. 2016;159:72–79. - PMC - PubMed
    1. Wen H, Hockenberry JM, Cummings JR. The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances. J Health Econ. 2015;42:64–80. - PubMed
    1. Cerdá M, Wall M, Keyes KM, Galea S, Hasin D. Medical marijuana laws in 50 states: iInvestigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug Alcohol Depend. 2012;120:22–27. - PMC - PubMed
    1. Williams AR, Olfson M, Kim J, Martins SS, Kleber H. Older, less regulated medical marijuana programs have much greater enrollment rates than newer ‘medicalized’ programs. Health Aff. 2016;35:480–8. - PMC - PubMed

Substances